ArticleScientific reports2025

Quality of life and symptom burden among hematologic malignancy patients undergoing CAR-T therapy: a cross-sectional study.

Hongyuan Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.